Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression, and peptidoglycan deacetylase activity by Shufeng Yang et al.
Yang et al. BMC Microbiology 2014, 14:174
http://www.biomedcentral.com/1471-2180/14/174RESEARCH ARTICLE Open AccessMycobacterium tuberculosis Rv1096 protein: gene
cloning, protein expression, and peptidoglycan
deacetylase activity
Shufeng Yang1,2, Fei Zhang1, Jian Kang1, Wenli Zhang1, Guoying Deng1,2, Yi Xin3 and Yufang Ma1,4*Abstract
Background: Many bacteria modulate and evade the immune defenses of their hosts through peptidoglycan (PG)
deacetylation. The PG deacetylases from Streptococcus pneumonia, Listeria monocytogenes and Lactococcus lactis
have been characterized. However, thus far, the PG deacetylase of Mycobacterium tuberculosis has not been
identified.
Results: In this study, we cloned the Rv1096 gene from the M. tuberculosis H37Rv strain and expressed Rv1096
protein in both Escherichia coli and M. smegmatis. The results showed that the purified Rv1096 protein possessed
metallo-dependent PG deacetylase activity, which increased in the presence of Co2+. The kinetic parameters of the PG
deacetylase towards M. smegmatis PG as a substrate were as follows: Km, 0.910 ± 0.007 mM; Vmax, 0.514 ± 0.038 μMmin−1;
and Kcat = 0.099 ± 0.007 (S
−1). Additionally, the viability of M. smegmatis in the presence of over-expressed Rv1096
protein was 109-fold higher than that of wild-type M. smegmatis after lysozyme treatment. Additionally, light
microscopy and scanning electron microscopy showed that in the presence of over-expressed Rv1096 protein,
M. smegmatis kept its regular shape, with an undamaged cell wall and smooth surface. These results indicate that
Rv1096 caused deacetylation of cell wall PG, leading to lysozyme resistance in M. smegmatis.
Conclusion: We have determined that M. tuberculosis Rv1096 is a PG deacetylase. The PG deacetylase activity of
Rv1096 contributed to lysozyme resistance in M. smegmatis. Our findings suggest that deacetylation of cell wall PG
may be involved in evasion of host immune defenses by M. tuberculosis.
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Mycobacterium tuberculosis, the agent of tuberculosis, is
associated with greater morbidity and longer dormancy in-
fection times in humans than any other type of bacterial
illness. Approximately one third of the population world-
wide are infected with M. tuberculosis, which causes nearly
two million deaths each year [1]. The chronic state and
dormancy of tuberculosis implies that M. tuberculosis has
developed sophisticated strategies to modify and evade the
innate and adaptive immune surveillance mechanisms of
humans [2].* Correspondence: yufang_ma@hotmail.com
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unless otherwise stated.M. tuberculosis has a distinctive cell wall structure, which
is called the “core” mycolyl arabinogalactan-peptidoglycan
(mAGP) complex. It is well-known that the bacterial cell
wall is a reservoir for many essential biomolecules that
interact with the surrounding environment. Peptidoglycan
(PG) the skeletal structure of the cell wall, enables bac-
teria to resist osmotic pressure. The nucleotide-binding
oligomerization domain (Nods) proteins in host cells,
which have been identified as unique intracellular pattern-
recognition receptors of PG and PG-derived muropeptides,
are potential virulence factors [3,4]. Therefore, bacteria
may have developed PG modification properties to modu-
late Nods-mediated host surveillance [3]. This is evidenced
from the role PG plays in the pathogenesis of Streptococcus
pneumoniae [5], Listeria monocytogenes [6] and Helicobac-
ter pylori [7].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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as S. pneumonia, L. monocytogenes and Lactococcus lac-
tis, prevents fusion of the phagosome with macrophage
lysozyme [5,8-13]. Although peptidoglycan deacetylase
has been identified in some bacteria [5-8], it has not yet
been identified in M. tuberculosis.
M. smegmatis is commonly used as a model for studying
gene function in M. tuberculosis because it proliferates
rapidly and is non-pathogenic. M. smegmatis and M. tu-
berculosis have the same basic cell wall structure [14].
Therefore, M. smegmatis peptidoglycan can be used as a
substrate to investigate peptidoglycan deacetylase activity.
In this study, we cloned M. tuberculosis Rv1096 and
expressed Rv1096 protein in Escherichia coli and M.
smegmatis. We determined the peptidoglycan deacety-
lase activity of purified Rv1096 and its biochemical char-
acteristics. We also investigated whether the Rv1096
protein in M. smegmatis was lysozyme resistant.
Methods
Bacterial strains and growth conditions
E. coli NovaBlue (Novagen, Madison, WI) and ER2566
(Novagen) strains were routinely grown in Luria-Bertani
media (LB, Invitrogen, Carlsbad, CA). The M. smegmatis
mc2155 (ATCC, USA) strain was grown in LB broth
containing 0.05% (v/v) Tween 80 (LBT) or LB agar at
37°C. Antibiotics were added at appropriate concentra-
tions if needed. To prepare PG, M. smegmatis mc2155
was grown in M9 minimal glucose medium (12.8 g so-
dium phosphate heptahydrate, 3 g potassium phosphate
monobasic, 0.5 g sodium chloride, 1 g ammonium chlor-
ide, 0.24 g magnesium sulfate, 4 g glucose and 11.1 mg
calcium chloride per L).
Rv1096 cloning and expression vector construction
The Rv1096 was amplified from M. tuberculosis H37Rv
genomic DNA (Colorado State University, USA) using
Pfu DNA polymerase with Rv1096 primer 1 (5′ TTCA-
TATGCCGAAGCGACCCGACAAC 3′; the NdeI site isTable 1 Bacteria and plasmids
Bacteria and plasmids Relevant characteristic(s)
Strains
E. coli NovaBlue Used for cloning and propagation of p
E. coli ER2566 Used for expression of Rv1096 protein
M. smegmatis mc2155 strain, used for expression of R
E. coli ER2566/Rv1096 E. coli ER2566 carrying pColdII-Rv1096 p
M. smegmatis/Rv1096 M. smegmatis mc2155 carrying pVV2-Rv
Plasmids
pJET1.2/blunt vector Carries ampR gene; used for cloning PC
pColdII-Rv1096 Carries ampR gene; used for expression
pVV2-Rv1096 Carries kanR gene; used for expressionitalics) and Rv1096 primer 2 (5′ GGCAAGCTTTACG
CACCGTTATTTGGC 3′; the HindIII site is italics).
The 876 bp PCR product was ligated to a pJET1.2 blunt
vector to generate a pJET-Rv1096 plasmid, the presence
of which was confirmed by DNA sequencing. Rv1096
was ligated to the NdeI and HindIII sites of pColdII
(Takara, Dalian, China) to generate the pColdII-Rv1096
plasmid for expression in E. coli. Rv1096 was also ligated
to the NdeI and HindIII sites of pVV2 (Colorado State
University, USA) to obtain the pVV2-Rv1096 M. smeg-
matis expression plasmid (Table 1).
Expression and purification of Rv1096 protein
The pColdII-Rv1096 plasmid was transformed into E. coli
ER2566 cells (Novagen) by a chemical transformation
method [15]. E. coli ER2566 harboring the pColdII-
Rv1096 plasmid (ER2566/Rv1096, Table 1) was grown in
300 ml of LB broth containing ampicillin (100 μg/ml) at
37°C. Isopropyl-D-thiogalactopyranoside at a final con-
centration of 1 mM was added to the culture when the
OD600 reached 0.5, after which the culture was incu-
bated at 16°C for 24 h.
The pVV2-Rv1096 plasmid was transformed into M.
smegmatis mc2155 using an electroporation method [15].
M. smegmatis mc2155 harboring the pVV2-Rv1096 plas-
mid (M. smegmatis/Rv1096, Table 1) was grown in 300 ml
of LBT broth with kanamycin at 50 μg/ml at 37°C for
24 h.
The cultures were centrifuged at 5000 × g for 15 min
and the cell pellets were resuspended in 5 ml of lysis
buffer (500 mM Tris-HCl, pH 8.0, 20 mM NaCl and
20% glycerol) with 1 mM phenylmethyl sulfonyl fluoride.
After sonication, the lysates were centrifuged at 15000 ×
g for 20 min and the supernatant fraction was loaded
onto a Ni-NTA column (Qiagen, Hilden, Germany) by
gravity flow. The column was washed with 20 ml of
wash buffer (20 mM Tris-HCl, pH 8.0, 500 mM NaCl,
20% glycerol and 30 mM imidazole). The purified pro-
tein was eluted with 10 ml of elution buffer (20 mMResource
lasmids Novagen
Novagen
v1096 protein and preparation of peptidoglycan ATCC
lasmid This work
1096 plasmid This work
R product Fermentas
Rv1096 protein in E. coli ER2566 This work
of Rv1096 protein in M. smegmatis mc2155 This work
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and the first 3 ml was collected for sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and west-
ern blotting, as well as deacetylase activity detection. The
purified protein (1.25 μg) was subjected to 12% SDS-PAGE
and then transferred to a nitrocellulose membrane (PALL,
NY, USA) in blotting buffer (20 mM Tris-base, 150 mM
glycine and 20% methanol, pH 8.3). After blocking with
10% non-fat dry milk in TBST buffer (10 mM Tris-HCl,
pH 8.0, 150 mM NaCl and 0.05% Tween 20), the mem-
brane was incubated with a monoclonal (anti)-polyhistidine
His-1 antibody (1:5000; Sigma-Aldrich). The membrane
was washed with TBST buffer three times and then incu-
bated with alkaline-phosphatase conjugated anti-mouse-
IgG (1:2500, Sigma-Aldrich). The His6-tagged-protein band
was visualized with 5-bromo-4-chloro-3-indolyl phosphate
and nitro blue tetrazolium (Sigma-Aldrich) solution.
Preparation of M. smegmatis PG
M. smegmatis PG was prepared from cell wall fractions as
described previously [16-18]. Briefly, a 500 ml culture of
M. smegmatis mc2155 in M9 minimal glucose medium
was harvested when the OD600 reached 0.6, after which
the cells were washed three times with pre-cooled phos-
phate buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 2 mM KH2PO4, pH 7.0). The pellets
were resuspended in distilled water to 0.2 g/ml, mixed
with an equal volume of boiling 8% SDS added drop-wise
with continuous boiling for 30 min. A cell-wall-enriched
fraction was obtained by centrifugation at 100,000 × g at
20°C for 60 min, followed by three washes with pre-cooled
PBS. The pellet was washed with distilled water at least six
times to remove the SDS. The sample was resuspended in
5 ml of buffer (10 mM Tris-HCl and 10 mM NaCl,
pH 7.0) and then sonicated for 5 min. α-amylase and imid-
azole were added to the sample at final concentrations of
100 μg/ml and 0.32 M, respectively, and the solution was
incubated at 37°C for 2 h to remove glycogen. Afterwards,
proteinase K was added to the sample at a final concentra-
tion of 100 μg/ml, followed by incubation at 37°C for 1.5 h
to remove lipoprotein. The proteinase K solution was then
inactivated by addition of an equal volume of boiling 8%
SDS with vigorous stirring for 15 min. The mixture was
ultracentrifuged at 100,000 × g at 20°C for 30 min. The
pelleted material was washed as described above. The
resulting mAGP (mycolyl-arabinogalactan-peptidoglycan)
complex was washed with acetone and dried under a
vacuum. Mycolic acids were removed with 1% potassium
hydroxide in methanol at 37°C for 72 h. After room
temperature centrifugation at 27,000 × g for 30 min, the pel-
leted arabinogalactan-PG was washed with distilled water
twice and dried under a vacuum. Arabinogalactan was re-
moved by washing with 49% hydrofluoridic acid at 4°C for
120 h with stirring. The resulting PG was pelleted by roomtemperature centrifugation at 27,000 × g for 30 min and
then washed as described above. The PG was dissolved in
50 mM HEPS buffer (pH 7.0) at 1 mg/ml until further use.
Deacetylase activity assays
The acetyl group released from the PG was measured
using an acetic acid detection kit (Roche, Darmstadt,
Germany). Briefly, Rv1096 protein (2.88 μg/ml) prepared
from ER2566/Rv1096 and M. smegmatis/Rv1096 were
separately incubated with M. smegmatis PG. The reactions
were performed at 37°C for 30 min and stopped by
10 min boiling. After room temperature centrifugation at
5000 × g for 10 min, the supernatant was collected for
acetic acid measurement using a spectrophotometric assay
accordingly to the kit instructions.
The kinetic properties of the Rv1096 protein toward
M. smegmatis PG were determined as described previ-
ously [19]. The molarity of M. smegmatis PG was calcu-
lated based the assumption that M. smegmatis PG is
primarily composed of repeat units of GlcNAc-MurNAc
(MurNGlyc)-L-Ala-D-Glu-A2pm, MW 868.8 [20-22]. First,
the initial velocity was evaluated according to the duration
of each reaction (5, 10, 15, 30 or 45 min) and the Rv1096
concentration (1.22, 2.88 or 3.65 μg/ml) curves. Then, the
optimal conditions for the enzymatic reactions were deter-
mined. Based on the initial velocity and the optimal condi-
tions that we identified, the steady-state kinetic parameters
were determined by a Lineweaver-Burke plot.
Lysozyme susceptibility assays
To investigate whether the Rv10196 protein contributed to
lysozyme resistance in M. smegmatis, wild-type M. smeg-
matis orM. smegmatis/Rv1096 with over-expressed Rv1096
protein were treated with lysozyme. Both bacterial strains
were incubated in LBT medium at 37°C. When the OD600
reached ~0.2, the cultures were divided into two equal
volumes parts. One part was treated with lysozyme (Sigma-
Aldrich) at a final concentration of 200 μg/ml; the other
was not given this treatment. Bacterial growth was moni-
tored by measuring the optical density at 600 nm. Bacterial
viability was evaluated by counting the number of colony
forming units (CFU) per milliliter on LB agar [23].
Morphology of the M. smegmatis strains after lysozyme
treatment
Light microscopy and electron microscopy were used to
investigate whether the Rv1096 protein affected the
morphology of M. smegmatis in the presence of lyso-
zyme. Bacteria that were treated with lysozyme for 9 h
were harvested by centrifugation at 4,500 × g at 4°C for
10 min, after which the pellets were washed with ste-
rilized 1 M PBS (pH 7.0), three times. Samples were pre-
pared for Ziehl-Neelsen acid-fast staining as described
previously [24], and observed under a light microscope
Yang et al. BMC Microbiology 2014, 14:174 Page 4 of 9
http://www.biomedcentral.com/1471-2180/14/174(Olympus CHB, Japan). The cells for electron microscopic
analysis were fixed with 2.5% glutaraldehyde, followed by
post-fixation at room temperature for 2 h with 1% os-
mium tetroxide. The samples were dehydrated with etha-
nol, which was replaced with liquid carbon dioxide by
critical point drying. The dried samples were applied to a
silicon wafer slide and sputter-coated with gold before
examination by an electronic microscope (JSM-6360 scan-
ning electron, JEOL, Japan).Statistical analysis
Data are summarized as mean value ± standard deviation
(SD). Data were assessed by two-tailed unpaired t tests. A
p value of <0.05 was considered statistically significant.Figure 1 Multiple sequence alignment of Rv1096, spPgdA, lmo0415 and
(gi:14972969); lmo0415, L. monocytogenes peptidoglycan GlcNAc deacetylase (g
(gi:281490824). Black regions indicate identical residues in the four proteins, whi
boxes. Two catalytic histidine residues (H-326 and H-330) are conserved among
ligand sites, Asp (D-275), Arg (A-295), Asp (D-391) and His (H-417) residues, whicResults
Rv1096 shares homology with other deacetylases
The amino acid sequences of the Rv1096 protein and other
known polysaccharide deacetylases [5,8-12] were com-
pared by Multalin analysis. The S. pneumoniae PgdA pro-
tein (spPdgA), L. monocytogenes PgdA (lmo0415) and L.
lactis PgdA (XynD) were identified as N-acetylglucosamine
deacetylase proteins containing CE-4 NodB domains
[10,25,26]. Rv1096 also contained a CE-4 NodB domain.
Rv1096 shared 31.6% sequence identity with the S. pneu-
moniae PgdA protein, whose deacetylase domain has
recently been defined as a crystal structure [10,25]. The
catalytic core of the amino acids involved in deacetylase
activity is highly conserved between Rv1096 and S. pneu-
moniae PgdA proteins (Figure 1).XynD proteins. spPgdA, S. pneumoniae peptidoglycan GlcNAc deacetylase
i:16409792); XynD, L. Lactis peptidoglycan GlcNAc deacetylase
le residues conserved between at least two of the proteins are marked by
Rv1096 and the other three deacetylases [10]. Rv1096 contains the metal
h were identified in the S. pneumonia PgdA protein.
Figure 2 Rv1096 protein analysis. SDS-PAGE (A) and western blot
(B) analysis of purified Rv1096 protein. Lane 1, purified Rv1096
protein over-expressed in M. smegmatis; Lane 2, purified Rv1096
protein over-expressed in E. coli. M, PageRuler™ Prestained Protein
Ladder (MBI Fermentas, Lithuania).
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soluble protein
Soluble Rv1096 protein, over-expressed in both E. coli and
M. smegmatis, was purified by Ni-NTA affinity chromatog-
raphy. The purified Rv196 protein was analyzed by SDS-
PAGE and western blotting (Figure 2). The results showed
that purified Rv1096 had a molecular weight of 35 kDa.Figure 3 PG deacetylase activity of purified Rv1096 protein. A) Acetic
smegmatis. PG (1 mg/ml) from wild-type M. smegmatis was used as a subs
(1.22, 2.88, 3.65 or 4.74 μg/ml). After incubation at 37°C for 30 min, acetyl g
Rv1096 protein over-expressed in E. coli and triangles indicate Rv1096 prot
course and concentration curve for Rv1096. Purified Rv1096 protein at 1.22
substrate at 37°C for 5, 10, 15, 30 and 50 min. Plotted values are means ± S
parameters were calculated by a double reciprocal plot. D) Rv1096 protein
cations (Mg2+, Mn2+, Co2+, Ca2+or Zn2+) were added to a final concentratioRv1096 exhibits peptidoglycan deacetylase activity
To assess its deacetylase activity, Rv1096 protein at 1.22,
2.88, 3.65 or 4.74 μg/ml was incubated with M. smegmatis
PG at 1 mg/ml. The acetyl group released from PG was
measured using an acetic acid detection kit (Roche Diag-
nostics, Germany). The results revealed that the purified
Rv1096 protein over-expressed in both E. coli and M.
smegmatis exhibited peptidoglycan deacetylase activity
(Figure 3A). There was no significant difference between
the Rv1096 proteins prepared from either bacterium in
terms of their specific enzymatic activities (p > 0.05).
Therefore, the Rv1096 protein prepared from E. coli was
used for the following enzyme kinetics experiments as it
was easier to prepare and produced a greater yield than
that produced in M. smegmatis.
According to the time versus concentration curve
(Figure 3B), when the Rv1096 protein concentration was
2.88 μg/ml, acetic acid was released at a constant rate over
a 30 min period. Therefore, the initial velocity range fell
within 30 min, and the optimal concentration for Rv1096
was 2.88 μg/ml. The optimal deacetylation reaction condi-
tions were determined by changing the pH and temperature
of the reaction. From this, the optimal pH was found
to be 7.0 and the optimal temperature 37°C (data not
shown). The kinetic parameters were calculated by aacid released by the Rv1096 protein over-expressed in E. coli and M.
trate and mixed with different concentrations of purified Rv1096
roup release was detected using an acetic acid kit. Squares indicate
ein over-expressed in M. smegmatis. Values are means ± SD. B) Time
, 2.88 or 3.65 μg/ml was incubated with M. smegmatis PG (1 mg/ml)
D. C) Km and Vmax values for Rv1096 PG deacetylase activity. Kinetic
exhibited a metallo dependent enzymatic activity. Various divalent
n of 0.5 μM. Values are mean ± SD.
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Vmax = 0.514 ± 0.038 μM min
−1; and Kcat = 0.099 ± 0.007
(S−1).
As shown in Figure 1, Rv1096 contained the same Asp-
His-His conserved residues known to interact with Co2+
in S. pneumoniae PgdA. To ensure that Rv1096 was also a
metallo-dependent deacetylase, various divalent cations
(Mg2+, Mn2+, Co2+, Ca2+ or Zn2+) were added to the reac-
tion buffer, each at a final concentration of 0.5 μM; EDTA
at 50 μM served as a control. The results showed that the
enzymatic reactivity reached the highest level in the pres-
ence of Co2+; however, enzymatic activity was lost in the
presence of EDTA (Figure 3D). Therefore, we determined
that Rv1096 is a metallo-dependent PG deacetylase.Figure 4 Lysozyme susceptibility assay. A) Lysozyme treatment
growth curves for M. smegmatis/Rv1096 and wild-type M. smegmatis.
M. smegmatis/Rv1096 (square) and wild-type M. smegmatis (triangle) were
grown in LBT medium at 37°C to an OD600 of 0.2; the cultures were then
divided into two parts. One part (closed symbol) was treated with
lysozyme, the other part was not. Three microliter samples from each
culture were collected at 1 h intervals for OD600 measurements.
M. smegmatis/Rv1096 showed significantly greater resistance to lysozyme
than did wild-type M. smegmatis (**P < 0.01). Values are means ± SD.
B) Cell survival curves for M. smegmatis/Rv1096 and wild-type M. smegmatis
under lysozyme treatment. M. smegmatis/Rv1096 (square) and wild-type
M. smegmatis (triangle) were each grown in LBT medium at 37°C to an
OD600 of 0.2, then the cultures were divided into two parts. One part
(closed symbol) was treated with lysozyme, the other part was not. Three
microliter culture samples were collected at 1 h intervals to measure
CFU/ml. M. smegmatis/Rv1096 exhibited greater cell survival than that of
the wild-type bacterium (**P < 0.01). Values are means ± SD.M. smegmatis/Rv1096 exhibits lysozyme resistance
To determine the contribution of Rv10196 protein to M.
smegmatis resistance to lysozyme, M. smegmatis/Rv1096
and wild-type M. smegmatis cultures were divided into
two parts at the beginning of the exponential growth
phase. Test samples received 200 μg/ml lysozyme, unlike
the control samples. As shown in Figure 4A, the wild-type
M. smegmatis culture suspension treated with lysozyme
lost its opaque, hazy appearance, becoming transparent at
the end of the exponential growth phase, or shortly after
reaching stationery phase. Its OD600 and CFU values de-
creased, indicating that cell lysis took place in the wild-
type lysozyme-treated M. smegmatis. The M. smegmatis/
Rv1096 growth curves for lysozyme treatment showed al-
most no difference to the lysozyme-untreated group, sug-
gesting that Rv10196 protein contributed to M. smegmatis
resistance to lysozyme degradation. There was also no sig-
nificant difference between the M. smegmatis/Rv1096 and
wild-type M. smegmatis treated with lysozyme in terms of
bacterial viability within the initial four hours of growth
(Figure 4B). However, viable wild-type M. smegmatis bac-
teria decreased rapidly after lysozyme treatment for 4 h. A
significant difference (P < 0.01) in viability was observed
between M. smegmatis/Rv1096 and wild-type M. smegma-
tis after lysozyme treatment for 9 h. About 107 wild-type
M. smegmatis cells survived, whereas only 1016 M. smeg-
matis/Rv1096 cells survived.The M. smegmatis/Rv1096 cell wall was undamaged by
9 h of lysozyme treatment
Because the most apparent differences in bacterial growth
and viability were observed (Figures 4A and B) after treat-
ment with lysozyme for 9 h, morphological observations
were performed at this time point. The results of the Ziehl-
Neelsen acid-fast staining showed that wild-type M. smeg-
matis lost its acid-fastness and became blue dyed, whereas
M. smegmatis/Rv1096 retained its acid-fastness (Figure 5).
Scanning electronic microscopy (SEM) showed that thewild-type M. smegmatis had an irregular appearance (en-
larged shape, destructed cell wall and wrinkled surface) in
the presence of lysozyme, whereas M. smegmatis/Rv1096
had a regular shape, undamaged cell wall and smooth sur-
face after 9 h lysozyme treatment (Figure 6).
Discussion
M. tuberculosis Rv1096 protein, S. pneumoniae PgdA
protein (spPdgA), L. monocytogenes PgdA (lmo0415),
and L. lactis PgdA (XynD) are carbohydrate esterase 4
(CE-4) superfamily members. The CE-4 superfamily in-
cludes peptidoglycan GlcNAc deacetylases, rhizobial
NodB chito-oligosaccharide deacetylases, chitin deace-
tylases, acetyl xylan esterases, and xylanases [27]. The
substrates of these enzymes are polymers or basic struc-
tures that assemble PG backbone glycan strands. In this
study, Rv1096 protein, over-expressed in both E. coli
Figure 5 Acid-fast staining of M. smegmatis/Rv1096 and wild-type cells. A) Wild-type M. smegmatis without lysozyme treatment,
B) wild-type M. smegmatis with lysozyme treatment, C) M. smegmatis/Rv1096 without lysozyme treatment and, D) M. smegmatis/Rv1096 with
lysozyme treatment (×1000). Lysozyme treatment was for 9 h.
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peptidoglycan. Therefore, M. tuberculosis Rv1096 pro-
tein is a peptidoglycan deacetylase.
As shown in Figure 1, Rv1096 and three other deacety-
lases share sequence conservation at two catalytic histidineFigure 6 Scanning electron micrographs of M. smegmatis/Rv1096 and w
treatment, B) wild-type M. smegmatis with lysozyme treatment, C) M. smegma
with lysozyme treatment. Lysozyme treatment was for 9 h.residues (H-326 and H-330) [10]. The metal ligand sites,
including Asp (D-275), Arg (A-295), Asp (D-391) and His
(H-417) residues, which were identified in the S. pneumo-
nia PgdA protein [5,10,28], are all present in the Rv1096
protein. These highly conserved sequences in Rv1096ild-type M. smegmatis. A) Wild-type M. smegmatis without lysozyme
tis/Rv1096 without lysozyme treatment and, D) M. smegmatis/Rv1096
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our results show that the enzymatic activity of Rv1096
increased after supplementation with divalent cations,
especially Co2+. Taken together, our results suggest that
Rv1096 may use similar catalytic mechanisms as the S.
pneumoniae PgdA protein to deacetylate PG.
It has been reported that PG deacetylase contributes to
lysozyme resistance in some bacterial species, such as
Bacillus cereus [29], S. pneumonia [10] , L. monocytogenes
[6] and Shigella flexneri [28]. Generally, pdgA mutants are
more sensitive to lysozyme degradation in the stationary
phase. Similarly, M. smegmatis over-expressing Rv1096
protein showed remarkable resistance to lysozyme at the
end of log phase growth. In the present study, the viability
of M. smegmatis/Rv1096 was 109-fold higher than that of
wild-type M. smegmatis after lysozyme treatment, indicat-
ing that PG deacetylation by the Rv1096 deacetylase had
increased lysozyme resistance. The morphological changes
observed between wild-type M. smegmatis and M. smeg-
matis/Rv1096 provides strong evidence that Rv1096 activ-
ity helped to preserve the integrity of the cell wall during
lysozyme treatment. Wild-type M. smegmatis lost its
acid-fastness because of the increased cell wall perme-
ability caused by lysozyme treatment. SEM observations
showed that wild-type M. smegmatis had a wrinkled cell
surface with outward spilling of its cell contents, while
M. smegmatis/Rv1096 maintained its cell wall integrity
and acid fastness. Therefore, it is likely that the func-
tionality of the Rv1096 protein of M. smegmatis/Rv1096
contributed to its cell wall integrity.
In fact, PG N-deacetylase has been shown to be a viru-
lence factor in several bacteria including S. pneumonia [5],
S. iniae [30], L. monocytogenes [12] and H. pylori [7]. For
example, the S. pneumoniae pdgA mutant (with a nonfunc-
tional pdgA gene) developed hypersensitivity to exogenous
lysozyme and decreased virulence in a mouse infection
model [5]. Furthermore, L. monocytogenes lacking pdgA
(lmo0415) was susceptible to macrophage clearance [12].
In further studies, we aim to establish whether the Rv1096
protein is a virulence factor.Conclusion
We identified M. tuberculosis Rv1096 as a PG deacetylase
and found that the PG deacetylase activity of this protein
contributed to lysozyme resistance in M. smegmatis. Our
findings suggest that PG deacetylation may be involved in
immune evasion by M. tuberculosis in its host.
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